FIELD: chemistry.
SUBSTANCE: invention relates to the new phenethanolamine derivatives having selective stimulant action at β2-adrenoreceptors and can be used for the treatment of respiratory diseases. In formula (I) m is an integer from 2 to 8, n is an integer from 3 to 11 with the proviso that the sum total of m and n is from 5 to 19, R1 represents SOR6 or SO2R6, where R6 represents a C3-7cycloalkyl group or a C3-7cycloalkelene group, R2 and R3 are independently derived from hydrogen and C1-6alkyl, each of R4 and R5 represents hydrogen, Ar represents a group selected from (a) and (b) where R8 represents hydrogen, halogen, -(CH2)qOR11, -NR11C(O)R12 or -NR11SO2R12, and R7 represents hydrogen, or R8 represents -NR11C(O)R12 and forms with R7 5- or 6-membered heterocyclic ring, R9 represents -OR11, R10 represents hydrogen, each of R11 and R12 independently represents hydrogen or C1-4alky, q is zero or an integer from 1 to 4. The invention also relates to the methods of compounds production and their application in pharmaceuticals production.
EFFECT: production of the new phenethanolamine derivatives having a selective stimulant action can be used for the treatment of respiratory disease.
16 cl, 5 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVE OF PHENETHANOLAMINE FOR TREATMENT OF RESPIRATORY DISEASE | 2002 |
|
RU2312854C2 |
DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS β2-ADRENERGIC RECEPTOR ANTAGONISTS | 2007 |
|
RU2451675C2 |
4-(2-AMINO-1-HYDROXYETHYL)PHENOL DERIVATIVES AS β2 ADRENERGIC RECEPTOR AGONISTS | 2006 |
|
RU2440330C2 |
TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2225407C2 |
3-PYRIDINE CARBOXAMIDE AND 2-PYRAZINE CARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | 2007 |
|
RU2454405C2 |
SUBSTITUTED ISOXAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INFLAMMATION SUPPRESSION | 1996 |
|
RU2200158C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
SPECIFIC GLYCOCORTICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2359973C2 |
AGENT WHICH PREVENTS PREMATURE OVULATION | 2006 |
|
RU2419435C2 |
POLYPEPTIDE COMPOUND | 2008 |
|
RU2470939C2 |
Authors
Dates
2008-08-27—Published
2003-10-24—Filed